ASH 2022 Conference Coverage
Playback speed
10 seconds
ASH 2022 Venetoclax Plus High-Dose Cytarabine and Mitoxantrone As Feasible and Effective Novel Treatment for Relapsed AML: Results of the Phase 1 SAL RELAX Trial
By
ASH 2022 Conference Coverage
FEATURING
Christoph Röllig
By
ASH 2022 Conference Coverage
FEATURING
Christoph Röllig
89 views
January 4, 2023
Login to view comments.
Click here to Login
Leukemia